The Mount Sinai Alcoholic Liver Disease Research Center aims to elucidate the pathogenesis of alcoholic liver injury and fibrosis due to oxidant stress. Read More
Ketamine Shows Significant Benefit in People with Treatment-Resistant Depression May 20, 2013 - Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic.
Degenerative Changes Identified in Spinal Discs and Reversed With Drug Cocktail In Diabetic Mice May 17, 2013 - The study, led by James C. Iatridis, PhD, was published in the journal PLOS ONE on May 17.
Icahn School of Medicine at Mount Sinai and Bene Pharmachem Gmbh To Collaborate On Clinical Studies For Mucopolysaccharidoses May 15, 2013 - The company, based in Germany, is the sole producer of pharmaceutical pentosan polysulfate.
Scott L. Friedman, MD
Arthur I. Cederbaum, PhD
